Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Early screening leads to drop in colorectal cancer:

This article was originally published in Clinica

Executive Summary

The reduction in colorectal cancer rates in the US since 1986 is probably due to better detection rates, says a study in the latest issue of Diseases of the Colon and Rectum (1999; 42). An annual drop of 1% over the past thirteen years is the result of early screening and the removal of precancerous polyps rather than lifestyle changes, the study believes. Colorectal cancer is believed to be linked to total fat consumption. Although Americans are eating less saturated fat, total fat consumption has not decreased, the study says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT079296

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel